Evaluating a SARS-CoV-2 screening strategy based on serological tests
- PMID: 33412810
- DOI: 10.19191/EP20.5-6.S2.118
Evaluating a SARS-CoV-2 screening strategy based on serological tests
Abstract
Background: facing the SARS-CoV-2 epidemic requires intensive testing on the population to early identify and isolate infected subjects. Although RT-PCR is the most reliable technique to detect ongoing infections, serological tests are frequently proposed as tools in heterogeneous screening strategies.
Objectives: to analyse the performance of a screening strategy proposed by the local government of Tuscany (Central Italy), which first uses qualitative rapid tests for antibody detection, and then RT-PCR tests on the positive subjects.
Methods: a simulation study is conducted to investigate the number of RT-PCR tests required by the screening strategy and the undetected ongoing infections in a pseudo-population of 500,000 subjects, under different prevalence scenarios and assuming a sensitivity of the serological test ranging from 0.50 to 0.80 (specificity 0.98). A compartmental model is used to predict the number of new infections generated by the false negatives two months after the screening, under different values of the infection reproduction number.
Results: assuming a sensitivity equal to 0.80 and a prevalence of 0.3%, the screening procedure would require on average 11,167 RT-PCR tests and would produce 300 false negatives, responsible after two months of a number of contagions ranging from 526 to 1,132, under the optimistic scenario of a reproduction number between 0.5 to 1. Resources and false negatives increase with the prevalence.
Conclusions: the analysed screening procedure should be avoided unless the prevalence and the rate of contagion are very low. The cost and effectiveness of the screening strategies should be evaluated in the actual context of the epidemic, accounting for the fact that it may change over time.
Keywords: sensitivity; serological test; specificity; false negative; compartmental model.
Similar articles
-
The risk of over-diagnosis in serological testing. Implications for communications strategies.Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):184-192. doi: 10.19191/EP20.5-6.S2.117. Epidemiol Prev. 2020. PMID: 33412809 English.
-
[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):200-206. doi: 10.19191/EP20.5-6.S2.119. Epidemiol Prev. 2020. PMID: 33412811 Italian.
-
Accuracy and cost description of rapid antigen test compared with reverse transcriptase-polymerase chain reaction for SARS-CoV-2 detection.Dan Med J. 2021 Jun 14;68(7):A03210217. Dan Med J. 2021. PMID: 34169830
-
In vitro diagnostics of coronavirus disease 2019: Technologies and application.J Microbiol Immunol Infect. 2021 Apr;54(2):164-174. doi: 10.1016/j.jmii.2020.05.016. Epub 2020 Jun 5. J Microbiol Immunol Infect. 2021. PMID: 32513617 Free PMC article. Review.
-
Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications.Biochem Soc Trans. 2020 Dec 18;48(6):2851-2863. doi: 10.1042/BST20200744. Biochem Soc Trans. 2020. PMID: 33170924 Review.
Cited by
-
Seroprevalence of Anti-SARS-CoV-2 IgG and IgM among Adults over 65 Years Old in the South of Italy.Diagnostics (Basel). 2021 Mar 9;11(3):483. doi: 10.3390/diagnostics11030483. Diagnostics (Basel). 2021. PMID: 33803299 Free PMC article.
-
Screening plans for SARS-CoV-2 based on sampling and rotation: An example in a European school setting.PLoS One. 2021 Sep 10;16(9):e0257099. doi: 10.1371/journal.pone.0257099. eCollection 2021. PLoS One. 2021. PMID: 34506536 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous